JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 28 No. 3 315-318
© 1987 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shulkin, B. L.
Right arrow Articles by Shapiro, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shulkin, B. L.
Right arrow Articles by Shapiro, B.

Iodine-131 MIBG Scintigraphy of the Extremities in Metastatic Pheochromocytoma and Neuroblastoma

Barry L. Shulkin, Shaio Wei Shen, James C. Sisson and Brahm Shapiro

Division of Nuclear Medicine, Department of Internal Medicine, University of Michigan Hospitals, Ann Arbor, Michigan

Correspondence: For reprints contact: B. Shapiro, MB, ChB, PhD, Div. of Nuclear Medicine, University of Michigan Hospitals, University Hospital B1G412/0028, 1500 E. Medical Center Dr., Ann Arbor, MI 48109/0028.

ABSTRACT

Iodine-131 MIBG scintigraphy may be used to determine the presence or absence of metastases to the appendicular skeleton in malignant pheochromocytoma and neuroblastoma. Normal bones show no uptake of [131I]MIBG and the joints are seen as photon-deficient areas surrounded by background muscle activity. Discrete concentrations of radioactivity in bone are often seen in patients with malignant pheochromocytoma and neuroblastoma. Bone marrow involvement in neuroblastoma may be indicated by diffuse uptake of [131I]MIBG or focal accumulation at the metaphyses. Uncommonly, bone involvement may not be displayed by the [131I]MIBG images. Since conventional bone scanning agents may also fail to detect these tumors, skeletal scintigraphy with both [131I]MIBG and [99mTc]MDP is necessary to reliably stage malignant pheochromocytoma and neuroblastoma.




This article has been cited by other articles:


Home page
Journal of Pediatric Oncology NursingHome page
J. U. Kelly
The Use of an Investigational Radiopharmaceutical in Neuroblastoma: A Nursing Perspective
Journal of Pediatric Oncology Nursing, January 1, 1989; 6(4): 133 - 138.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1987 by the Society of Nuclear Medicine.